期刊文献+

川崎病65例疗效分析

Effective Analysis of Treatment of 65 Cases of Kawasaki Disease
下载PDF
导出
摘要 目的 探讨治疗川崎病的最佳方法。方法 将 6 5例川崎病患儿根据用药情况分为A组 (单用阿斯匹林 )、B组 (阿斯匹林加静脉丙种球蛋白 0 .4 g/ (kg·d) ,用 3~ 5d)、C组 (阿斯匹林加静脉丙种球蛋白 1~ 2 g/(kg·次 ) ,用 1次、D组 (单用肾上腺皮质激素 ) ,对各组疗效进行对比与分析。 结果 A组、B组、C组平均退热时间分别为 5.6d、2 .8d、1.8d ,冠状动脉扩张发生率分别为 38.9%、14.3%、4 .5%。经t或 χ2 检验处理 ,差异显著 (P <0 .0 1) ,治疗效果C组 >B组 >A组。D组均发生冠状动脉瘤 (10 0 % )。结论 C组疗法可作为治疗川崎病预防冠状动脉损害的方法。 Objective To study the best way of treating kawasaki disease.Methods 65 cases were divided into four groups according to the different methods of taking medicine, they were group A (only ASP),group B (ASP+IVIG 0.4g/kg/day×3-5 days),group C (ASP+IVIG1-2 gram/kg/time×once),group D (only hormone), their curative effects were compared and analyzed. Results The average time recovering fever of A、B、C group was respectively 5.6 days,2.8 days and 1.8 days, the incidence of CAD was respectively 38.9%,14.3% and 4.5%, the two were given t or X 2 test, there were obvious differences between them (P<0.01), the group C was highest and the group B was higher than the group A in their curative effect. The group D all happened CAA (100%). Conclusion The group C therapy might be the first way of treating kawasaki disease.
机构地区 菏泽市人民医院
出处 《菏泽医学专科学校学报》 2000年第2期55-56,共2页 Journal of Heze Medical College
关键词 阿斯匹林/治疗应用 静脉丙种球蛋白/治疗应用 川崎病/治疗 治疗 ASP/therapeutic use IvIG/therapeutic use kawasaki disease/therapy
  • 相关文献

参考文献2

二级参考文献4

  • 1Gong J,Cell Prolif,1994年,27卷,357页 被引量:1
  • 2邓仲端,中华病理学杂志,1993年,22卷,163页 被引量:1
  • 3阮秋蓉,中华病理学杂志,1991年,20卷,205页 被引量:1
  • 4金冬雁(译),分子克隆实验指南(第2版),1985年,362页 被引量:1

共引文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部